Paper213976
Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
Pavan-Langston D and 2 others. Am J Ophthalmol, 1978. Cited by 67 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Acyclic antimetabolite therapy of experimental herpes simplex keratitis. Papers, record 213976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/213976
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Guanosine | Major topic |
| Keratitis, Dendritic | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Idoxuridine | |
| Male | |
| Rabbits | |
| Simplexvirus | |
| Vidarabine |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8695561 | Clinical evaluation of carbocyclic oxetanocin G eyedrops in the treatment of herpes simplex corneal ulcers. | Br J Ophthalmol | 1996 | https://conductscience.org/library/papers/8695561 | PubMed |
| 7352751 | (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7352751 | PubMed |
| 7043864 | A double-controlled evaluation of acyclovir and vidarabine for the treatment of herpes simplex epithelial keratitis. | Trans Am Ophthalmol Soc | 1981 | https://conductscience.org/library/papers/7043864 | PubMed |
| 7000171 | Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/7000171 | PubMed |
| 6809036 | Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial. | Br J Ophthalmol | 1982 | https://conductscience.org/library/papers/6809036 | PubMed |
| 6785059 | Aciclovir and trifluorothymidine in herpetic keratitis. Preliminary report of a multicentered trial. | Doc Ophthalmol | 1981 | https://conductscience.org/library/papers/6785059 | PubMed |
| 6662013 | Acyclovir treatment in stromal herpetic keratitis. | Doc Ophthalmol | 1983 | https://conductscience.org/library/papers/6662013 | PubMed |
| 6315332 | Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. | Drugs | 1983 | https://conductscience.org/library/papers/6315332 | PubMed |
| 6303216 | Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6303216 | PubMed |
| 6282195 | Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6282195 | PubMed |
| 6275777 | Quantitation of herpes simplex virus type 1 shed in preocular tear film of rabbits treated with acyclovir. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6275777 | PubMed |
| 6251373 | Strategies of drug resistance in herpes simplex. | Nature | 1980 | https://conductscience.org/library/papers/6251373 | PubMed |
| 6249751 | Comparative in vitro imunotoxicology of acyclovir and other antiviral agents. | Infect Immun | 1980 | https://conductscience.org/library/papers/6249751 | PubMed |
| 6247967 | In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6247967 | PubMed |
| 2991155 | Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis. | Int Ophthalmol | 1985 | https://conductscience.org/library/papers/2991155 | PubMed |
| 2653790 | Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. | Drugs | 1989 | https://conductscience.org/library/papers/2653790 | PubMed |
| 2499895 | Rapid and accurate viral diagnosis. | Pharmacol Ther | 1989 | https://conductscience.org/library/papers/2499895 | PubMed |
| 1965619 | Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease. | Trans Am Ophthalmol Soc | 1990 | https://conductscience.org/library/papers/1965619 | PubMed |
| 475362 | Therapy of experimental herpes simplex encephalitis with aciclovir in mice. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/475362 | PubMed |
| 465415 | Efficacy of acycloguanosine against herpetic ulcers in rabbit cornea. | Br J Ophthalmol | 1979 | https://conductscience.org/library/papers/465415 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/213976
GET https://conductscience.org/api/papers/v1/213976/authors